Page 59 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 59
15. Italiano A. Prognostic or predictive? It’s time to get back to definitions! Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 2011;29(35):4718;
author reply -9. 2
16. Campos NG, Burger EA, Sy S, et al. An Updated Natural History Model of Cervical Cancer: Derivation of Model Parameters. American journal of epidemiology. 2014 Sep 1; 180(5):545- 55.
17. Wang SS, Hildesheim A. Chapter 5: Viral and host factors in human papillomavirus persistence and progression. Journal of the National Cancer Institute Monographs. 2003(31):35-40.
18. Baak JP, Kruse AJ, Robboy SJ, Janssen EA, van Diermen B, Skaland I. Dynamic behavioural
interpretation of cervical intraepithelial neoplasia with molecular biomarkers. Journal of
clinical pathology. 2006;59(10):1017-28.
19. Moscicki AB, Schiffman M, Burchell A, et al. Updating the natural history of human
papillomavirus and anogenital cancers. Vaccine. 2012;30 Suppl 5:F24-33.
20. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. Journal of the
National Cancer Institute. 2008;100(20):1432-8.
* this paper provides a method to determine applicability of diagnostic and prognostic
candidate biomarkers
21. Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi) genetic changes in HPV-induced cervical precancerous lesions. Nature reviews Cancer. 2014;14(6):395-405.
** this paper provides an excellent overview of current knowledge on (epi)genetic changes in CIN
22. Lungu O, Sun XW, Felix J, Richart RM, Silverstein S, Wright TC, Jr. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA : the journal of the American Medical Association. 1992;267(18):2493-6.
23. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2000;19(1-2):1-5.
24. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24 Suppl 1:S1-15.
25. Syrjanen K, Hakama M, Saarikoski S, et al. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sexually transmitted diseases. 1990;17(1):15-9.
26. Cuschieri KS, Cubie HA, Whitley MW, et al. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. Journal of clinical pathology. 2005;58(9):946-50.
27. Winer RL, Hughes JP, Feng Q, et al. Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011;20(4):699-707.
A review of prognostic biomarkers
57
